AF
ATRS

Amalgamated Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Amalgamated Financial’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$111K Buy
+27,177
New +$98.6K ﹤0.01% 2111

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Amalgamated Financial's ATRS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Antares Pharma, Inc. (ATRS) in Q1 2022: 27,177 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #2111 among its holdings.

177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

  • Amalgamated Financial held 27,177 shares of Antares Pharma, Inc. worth $111K as of Q1 2022.
  • Antares Pharma, Inc. was a new Amalgamated Financial position in Q1 2022.
  • Antares Pharma, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2111 holding.
  • 177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.